Mechanism underlying the inhibitory effect of Apelin‑13 on glucose deprivation‑induced autophagy in rat cardiomyocytes

Jiao,Hui; Zhang,Zhi; Ma,Qinghua; Fu,Wei; Liu,Zidong

doi:10.3892/etm.2013.902

Mechanism underlying the inhibitory effect of Apelin‑13 on glucose deprivation‑induced autophagy in rat cardiomyocytes

Authors:
- Hui Jiao
- Zhi Zhang
- Qinghua Ma
- Wei Fu
- Zidong Liu
View Affiliations

Affiliations: Department of Cardiology, The Third Affilated Hospital of Liaoning Medical University, Jinzhou 121001, P.R. China
Published online on: January 17, 2013 https://doi.org/10.3892/etm.2013.902
Pages: 797-802

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to investigate the effect of Apelin‑13 on cardiomyocyte autophagy and to determine the underlying mechanism of this effect. To establish an autophagic model system, the cardiomyocytes of Sprague Dawley rats (postnatal day 3) were cultured and divided into five groups: normal control (Co), glucose deprivation (GD), GD+Apelin‑13, GD+Apelin‑13 treated with the Akt‑specific inhibitor triciribine (GD+Apelin‑13+Triciribine) and triciribine alone (Triciribine). The intracellular autophagosomes were then observed using transmission electron microscopy (TEM) and the expression levels of cellular autophagy‑related protein microtubule‑associated protein 1 light chain 3 (LC3), phosphatidylinositol‑3‑kinase (PI3K) and mammalian target of rapamycin (mTOR) protein were measured using western blotting. Compared with the Co group, the ratio of LC3‑II/LC3‑I increased significantly in all treatment groups, with the exception of the Triciribine group (P<0.05). Compared with the GD group, the ratio of LC3‑II/LC3‑I was significantly decreased, and the PI3K and mTOR expression was significantly enhanced in the GD+Apelin‑13 and GD+Apelin‑13+Triciribine groups (P<0.05). Compared with the GD+Apelin‑13 group, the ratio of LC3‑II/LC3‑I increased significantly (P<0.05) and the PI3K expression remained unchanged in the GD+Apelin‑13+Triciribine group (P>0.05), but mTOR expression was significantly reduced (P<0.05). GD led to increased numbers of autophagosomes and augmented the LC3‑II/LC3‑I ratio (P<0.05). Apelin‑13 pretreatment attenuated GD‑induced cardiomyocte injury, decreased the autophagosome number and the ratio of LC3‑II/ LC3‑I (P<0.05), enhanced PI3K activity (P<0.05) and upregulated the phosphorylation levels of the Akt and mTOR proteins (P<0.05). The Akt‑specific inhibitor triciribine weakened the protective role of Apelin‑13 (P<0.05). To a certain extent, Apelin‑13 inhibited GD‑induced cardiomyocyte autophagy, which may be related in part to the activation of the PI3K/Akt/mTOR signaling pathway.

View Figures

View References

1.	Matsui Y, Takagi H, Qu X, et al: Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circ Res. 100:914–922. 2007. View Article : Google Scholar
2.	Kroemer G and Levine B: Autophagic cell death: the story of a misnomer. Nat Rev Mol Cell Biol. 9:1004–1010. 2008. View Article : Google Scholar : PubMed/NCBI
3.	Sorli SC, van den Berghe L, Masri B, Knibiehler B and Audigier Y: Therapeutic potential of interfering with apelin signalling. Drug Discov Today. 11:1100–1106. 2006. View Article : Google Scholar : PubMed/NCBI
4.	Dutta D, Calvani R, Bernabei R, Leeuwenburgh C and Marzetti E: Contribution of impaired mitochondrial autophagy to cardiac aging: mechanisms and therapeutic opportunities. Circ Res. 110:1125–1138. 2012. View Article : Google Scholar : PubMed/NCBI
5.	Quazi R, Palaniswamy C and Frishman WH: The emerging role of apelin in cardiovascular disease and health. Cardiol Rev. 17:283–286. 2009. View Article : Google Scholar : PubMed/NCBI
6.	Tycinska AM, Lisowska A, Musial WJ and Sobkowicz B: Apelin in acute myocardial infarction and heart failure induced by ischemia. Clin Chim Acta. 413:406–410. 2012. View Article : Google Scholar : PubMed/NCBI
7.	Ren X and Zhang Z: Effect of Apelin-13 on glucose deprivation-induced rat myocardial cell autophagy. Guangdong Yi Xue. 32:3176–3177. 2011.(In Chinese).
8.	Zhu S, Sun F, Li W, et al: Apelin stimulates glucose uptake through the PI3K/Akt pathway and improves insulin resistance in 3T3-L1 adipocytes. Mol Cell Biochem. 353:305–313. 2011. View Article : Google Scholar : PubMed/NCBI
9.	Tatemoto K, Hosoya M, Habata Y, et al: Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun. 251:471–476. 1998. View Article : Google Scholar : PubMed/NCBI
10.	Zhang Z, Yu B and Tao GZ: Apelin protects against cardiomyocyte apoptosis induced by glucose deprivation. Chin Med J (Engl). 122:2360–2365. 2009.PubMed/NCBI
11.	Xin Y, Xu X and Huang Y: Isolation, primary culture and identification of cardiac fibroblasts and cardiac myocytes of neonatal mouse. Xinjiang Yi Xue Yuan Xue Bao. 28:541–547. 2011.(In Chinese).
12.	Folli F, Saad MJ, Backer JM and Kahn CR: Insulin stimulation of phosphatidylinositol 3-kinase activity and association with insulin receptor substrate 1 in liver and muscle of the intact rat. J Biol Chem. 267:22171–22177. 1992.PubMed/NCBI
13.	Wohlgemuth SE, Seo AY, Marzetti E, Lees HA and Leeuwenburgh C: Skeletal muscle autophagy and apoptosis during aging: effects of calorie restriction and life-long exercise. Exp Gerontol. 45:138–148. 2010. View Article : Google Scholar : PubMed/NCBI
14.	Tatemoto K: Search for an endogenous ligand of the orphan G protein-coupled receptor - discovery of apelin, a novel biologically active peptide. Nihon Rinsho. 58:737–746. 2000.(In Japanese).
15.	Galanth C, Hus-Citharel A, Li B and Llorens-Cortès C: Apelin in the control of body fluid homeostasis and cardiovascular functions. Curr Pharm Des. 18:789–798. 2012. View Article : Google Scholar : PubMed/NCBI
16.	Tempel D, de Boer M, van Deel ED, et al: Apelin enhances cardiac neovascularization after myocardial infarction by recruiting aplnr+ circulating cells. Circ Res. 111:585–598. 2012.PubMed/NCBI
17.	Balasis ME, Forinash KD, Chen YA, et al: Combination of farnesyltransferase and Akt inhibitors is synergistic in breast cancer cells and causes significant breast tumor regression in ErbB2 transgenic mice. Clin Cancer Res. 17:2852–2862. 2011. View Article : Google Scholar : PubMed/NCBI
18.	Dieterle A, Orth R, Daubrawa M, et al: The Akt inhibitor triciribine sensitizes prostate carcinoma cells to TRAIL-induced apoptosis. Int J Cancer. 125:932–941. 2009. View Article : Google Scholar : PubMed/NCBI
19.	Chen Y, Azad MB and Gibson SB: Methods for detecting autophagy and determining autophagy-induced cell death. Can J Physiol Pharmacol. 88:285–295. 2010. View Article : Google Scholar : PubMed/NCBI
20.	Martinet W, De Meyer GR, Andries L, Herman AG and Kockx MM: In situ detection of starvation-induced autophagy. J Histochem Cytochem. 54:85–96. 2006. View Article : Google Scholar : PubMed/NCBI
21.	Arad M, Seidman CE and Seidman JG: AMP-activated protein kinase in the heart: role during health and disease. Circ Res. 100:474–488. 2007. View Article : Google Scholar : PubMed/NCBI
22.	Hardie DG: AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. Nat Rev Mol Cell Biol. 8:774–785. 2007. View Article : Google Scholar : PubMed/NCBI
23.	Yu L, McPhee CK, Zheng L, et al: Termination of autophagy and reformation of lysosomes regulated by mTOR. Nature. 465:942–946. 2010. View Article : Google Scholar : PubMed/NCBI
24.	Gottlieb RA, Finley KD and Mentzer RM Jr: Cardioprotection requires taking out the trash. Basic Res Cardiol. 104:169–180. 2009. View Article : Google Scholar : PubMed/NCBI
25.	Cuervo AM: Autophagy: in sickness and in health. Trends Cell Biol. 14:70–77. 2004. View Article : Google Scholar : PubMed/NCBI